RxDoctor Payments Data

Steven Oberlender

MOHS-Micrographic Surgery · Allentown, PANPI 1902893001

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $621 of the $740 with a category attached, or 84.0%. 11 manufacturers reported payments, led by Sanofi at 32.7% of the total. Reporting peaked in 2024 at $292 and has fallen 69.0% since, to $90 in 2025. That places this record below the midpoint for mohs-micrographic surgery clinicians in PA, where the typical reported total is $1,161.

$740in general payments, 2019–2025

Across 34 payments — averaging $21.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$242
  • Johnson & Johnson$143
  • AbbVie$141
  • Amgen$66
  • Genentech USA, Inc.$47
  • Kyowa Kirin, Inc.$24
  • plus $79 from 5 others

What the payments were for

  • Food & beverage$62184%
  • Education$11816%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sanofi11$242
Johnson & Johnson4$143
AbbVie8$141
Amgen3$66
Genentech USA, Inc.2$47
Kyowa Kirin, Inc.1$24
Bristol Myers Squibb1$23
Kerecis Limited1$17
Pfizer1$16
Conmed Corporation1$14
Prugen, Inc. Pharmaceuticals1$10

How this compares

$740 in reported general payments places this provider in the 35th percentile of 48 mohs-micrographic surgery providers in Pennsylvania.

See all mohs-micrographic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$845,401
Medicare patients
635
Services billed
2,643

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin153$1,085
Fluorouracil13$793

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Allentown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →